These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

558 related items for PubMed ID: 9852124

  • 1. Insulin receptor substrate 2 and Shc play different roles in insulin-like growth factor I signaling.
    Kim B, Cheng HL, Margolis B, Feldman EL.
    J Biol Chem; 1998 Dec 18; 273(51):34543-50. PubMed ID: 9852124
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Differential regulation of insulin receptor substrate-2 and mitogen-activated protein kinase tyrosine phosphorylation by phosphatidylinositol 3-kinase inhibitors in SH-SY5Y human neuroblastoma cells.
    Kim B, Leventhal PS, White MF, Feldman EL.
    Endocrinology; 1998 Dec 18; 139(12):4881-9. PubMed ID: 9832424
    [Abstract] [Full Text] [Related]

  • 4. Signalling pathways of insulin-like growth factor-I that are augmented by cAMP in FRTL-5 cells.
    Ariga M, Nedachi T, Akahori M, Sakamoto H, Ito Y, Hakuno F, Takahashi S.
    Biochem J; 2000 Jun 01; 348 Pt 2(Pt 2):409-16. PubMed ID: 10816436
    [Abstract] [Full Text] [Related]

  • 5. Roles of insulin receptor substrate-1 and Shc on insulin-like growth factor I receptor signaling in early passages of cultured human fibroblasts.
    Takahashi Y, Tobe K, Kadowaki H, Katsumata D, Fukushima Y, Yazaki Y, Akanuma Y, Kadowaki T.
    Endocrinology; 1997 Feb 01; 138(2):741-50. PubMed ID: 9003010
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the insulin and insulin-like growth factor 1 mitogenic intracellular signaling pathways.
    Sasaoka T, Ishiki M, Sawa T, Ishihara H, Takata Y, Imamura T, Usui I, Olefsky JM, Kobayashi M.
    Endocrinology; 1996 Oct 01; 137(10):4427-34. PubMed ID: 8828504
    [Abstract] [Full Text] [Related]

  • 7. Tyrosine phosphorylation-dependent and -independent role of Shc in the regulation of IGF-1-induced mitogenesis and glycogen synthesis.
    Sasaoka T, Ishiki M, Wada T, Hori H, Hirai H, Haruta T, Ishihara H, Kobayashi M.
    Endocrinology; 2001 Dec 01; 142(12):5226-35. PubMed ID: 11713219
    [Abstract] [Full Text] [Related]

  • 8. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.
    Guvakova MA, Surmacz E.
    Cancer Res; 1997 Jul 01; 57(13):2606-10. PubMed ID: 9205064
    [Abstract] [Full Text] [Related]

  • 9. PTEN inhibits insulin-stimulated MEK/MAPK activation and cell growth by blocking IRS-1 phosphorylation and IRS-1/Grb-2/Sos complex formation in a breast cancer model.
    Weng LP, Smith WM, Brown JL, Eng C.
    Hum Mol Genet; 2001 Mar 15; 10(6):605-16. PubMed ID: 11230180
    [Abstract] [Full Text] [Related]

  • 10. Insulin receptor substrate (IRS) proteins IRS-1 and IRS-2 differential signaling in the insulin/insulin-like growth factor-I pathways in fetal brown adipocytes.
    Valverde AM, Lorenzo M, Pons S, White MF, Benito M.
    Mol Endocrinol; 1998 May 15; 12(5):688-97. PubMed ID: 9605931
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Growth hormone stimulates the tyrosine kinase activity of JAK2 and induces tyrosine phosphorylation of insulin receptor substrates and Shc in rat tissues.
    Thirone AC, Carvalho CR, Saad MJ.
    Endocrinology; 1999 Jan 15; 140(1):55-62. PubMed ID: 9886807
    [Abstract] [Full Text] [Related]

  • 13. Insulin signals to prenyltransferases via the Shc branch of intracellular signaling.
    Goalstone ML, Leitner JW, Berhanu P, Sharma PM, Olefsky JM, Draznin B.
    J Biol Chem; 2001 Apr 20; 276(16):12805-12. PubMed ID: 11278505
    [Abstract] [Full Text] [Related]

  • 14. Association between GRB2/Sos and insulin receptor substrate 1 is not sufficient for activation of extracellular signal-regulated kinases by interleukin-4: implications for Ras activation by insulin.
    Pruett W, Yuan Y, Rose E, Batzer AG, Harada N, Skolnik EY.
    Mol Cell Biol; 1995 Mar 20; 15(3):1778-85. PubMed ID: 7862167
    [Abstract] [Full Text] [Related]

  • 15. Increased insulin sensitivity in IGF-I receptor--deficient brown adipocytes.
    Mur C, Valverde AM, Kahn CR, Benito M.
    Diabetes; 2002 Mar 20; 51(3):743-54. PubMed ID: 11872675
    [Abstract] [Full Text] [Related]

  • 16. Different pathways of postreceptor desensitization following chronic insulin treatment and in cells overexpressing constitutively active insulin receptors.
    Inoue G, Cheatham B, Kahn CR.
    J Biol Chem; 1996 Nov 08; 271(45):28206-11. PubMed ID: 8910437
    [Abstract] [Full Text] [Related]

  • 17. Functional importance of Shc tyrosine 317 on insulin signaling in Rat1 fibroblasts expressing insulin receptors.
    Ishihara H, Sasaoka T, Ishiki M, Takata Y, Imamura T, Usui I, Langlois WJ, Sawa T, Kobayashi M.
    J Biol Chem; 1997 Apr 04; 272(14):9581-6. PubMed ID: 9083103
    [Abstract] [Full Text] [Related]

  • 18. Shc is the predominant signaling molecule coupling insulin receptors to activation of guanine nucleotide releasing factor and p21ras-GTP formation.
    Sasaoka T, Draznin B, Leitner JW, Langlois WJ, Olefsky JM.
    J Biol Chem; 1994 Apr 08; 269(14):10734-8. PubMed ID: 8144662
    [Abstract] [Full Text] [Related]

  • 19. Functional importance of amino-terminal domain of Shc for interaction with insulin and epidermal growth factor receptors in phosphorylation-independent manner.
    Sasaoka T, Ishihara H, Sawa T, Ishiki M, Morioka H, Imamura T, Usui I, Takata Y, Kobayashi M.
    J Biol Chem; 1996 Aug 16; 271(33):20082-7. PubMed ID: 8702728
    [Abstract] [Full Text] [Related]

  • 20. Src-family tyrosine kinases in activation of ERK-1 and p85/p110-phosphatidylinositol 3-kinase by G/CCKB receptors.
    Daulhac L, Kowalski-Chauvel A, Pradayrol L, Vaysse N, Seva C.
    J Biol Chem; 1999 Jul 16; 274(29):20657-63. PubMed ID: 10400698
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.